The pre-metastatic niche: finding common ground (Q34342357)

1 August 2017

The pre-metastatic niche: finding common ground (English)

1 reference

1 August 2017

Mark J Smyth

2

0 references

author name string

Jaclyn Sceneay

series ordinal

1

1 reference

PubMed ID

23636348

1 August 2017

Andreas Möller

series ordinal

3

1 reference

1 August 2017

1 December 2013

1 reference

Cancer and Metastasis Reviews

1 August 2017

1 reference

1 August 2017

32

1 reference

1 August 2017

449-464

1 reference

1 August 2017

3-4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-013-9420-1

1 August 2017

0 references

cites work

Cancer metastasis: building a framework

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Cancer. The metastasis cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Remarks on a Case of Alternate Partial Anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

No common denominator for breast cancer lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

VEGFR1-activity-independent metastasis formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid cell diversification and complexity: an old concept with new turns in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Cancer dormancy: a model of early dissemination and late cancer recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Cancer of unknown primary site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Controversies in clinical cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Molecular mechanisms underlying tumor dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Exosomes: immune properties and potential clinical implementations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

CD44v6 dependence of premetastatic niche preparation by exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Impaired circulating myeloid DCs from myeloma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tumor exosomes inhibit differentiation of bone marrow dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

New views on natural killer cell-based immunotherapy for melanoma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Induction of myeloid-derived suppressor cells by tumor exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-013-9420-1

10.1007/S10555-013-9420-1

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

23636348

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

23636348